SUPREME COURT ISSUES NOTICE IN PLEA SEEKING GUIDELINES AGAINST MANUFACTURING AND SELLING OF FAKE PHARMA DRUGS

The petition filed states that on September 8, 2024 where the custom department raided certain premises in Kolkata and apprehended two individuals for using the premises to package, store and supply fake or spurious branded and generic drugs.

- 

The Supreme Court in the case Indian Pharmaceutical Alliance Versus Union Of India observed and has agreed to consider the issue of lack of procedural guidelines in initiating criminal proceedings against the offence of manufacturing, storing and selling of counterfeited drugs.

The bench comprising of Justice JB Pardiwala and Justice R Mahadevan was hearing the present matter.

The bench in the case issued notice in the plea.

In the present case, the petition has been filed by the Indian Pharmaceutical Alliance, IPA wherein it seeks directions to the Union to frame procedural guidelines to initiate criminal proceedings against persons selling or manufacturing fake drugs and medicines.

It has been stated by Indian Pharmaceutical Alliance, IPA that the serious life threat such dubious drugs could cause to the patients, and the rampant manufacturing and selling in the market affected the pharmaceutical industry, violating Article 21 and Article 19(1)(g) of the Constitution of India.